Allowing for 2017 financing
TARGET CHANGE
CHANGE IN TARGET PRICE€ 0.35 vs 0.68 -48.0%
The sharp drop in the target price is due to an overdue set of adjustments that combines the H1 17 release and the dilution associated with financing, as well as a full resetting of forecasts to allow for various delays.
CHANGE IN EPS2017 : € -0.11 vs 0.02 ns
2018 : € 0.01 vs 0.05 -85.0%
Updates to fragile forecasting models and dilution factors lead to significant corrections. 2017 earnings have al ....
01 Feb 2018
Allowing for 2017 financing (Europlasma)
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Allowing for 2017 financing (Europlasma)
Allowing for 2017 financing
TARGET CHANGE
CHANGE IN TARGET PRICE€ 0.35 vs 0.68 -48.0%
The sharp drop in the target price is due to an overdue set of adjustments that combines the H1 17 release and the dilution associated with financing, as well as a full resetting of forecasts to allow for various delays.
CHANGE IN EPS2017 : € -0.11 vs 0.02 ns
2018 : € 0.01 vs 0.05 -85.0%
Updates to fragile forecasting models and dilution factors lead to significant corrections. 2017 earnings have al ....